1. Universal screening of colorectal tumors for lynch syndrome: a survey of patient experiences and opinions
- Author
-
Petterson, Alexander T., Garbarini, Jennifer, and Baker, Maria J.
- Subjects
Immunohistochemistry -- Health aspects ,Medical centers -- Health aspects ,Tumors -- Genetic aspects ,Colon cancer -- Genetic aspects ,Endometrial cancer -- Genetic aspects ,Genetic screening -- Genetic aspects -- Health aspects ,Medical screening -- Health aspects ,Health ,National Comprehensive Cancer Network -- Ethical aspects - Abstract
Background Lynch syndrome represents the most common hereditary cause of both colorectal and endometrial cancer. It is caused by defects in mismatch repair genes, as well as EPCAM. Universal screening of colon tumors for Lynch syndrome via microsatellite instability (MSI) and/or immunohistochemistry (IHC) can identify patients and families at risk to develop further cancers and potentially impact surveillance and treatment options. The approach to implementation of universal screening, taking ethical considerations into account, is critical to its effectiveness, with patient perspectives providing valuable insight. Methods Patients whose colon tumors underwent universal screening at Penn State Hershey Medical Center over a period of 2.5 years were mailed a survey on universal screening in 2017. Along with the survey, they received a recruitment letter and a summary explanation of research. The survey included both multiple choice and free-response questions that covered topics including respondent knowledge of Lynch syndrome, attitudes toward universal screening and experiences with the screening protocol as implemented. Results Sixty-six of 297 possible patients (22.2%) responded to the survey, including 13 whose screening results raised concern for Lynch syndrome. 75.8% of respondents supported universal tumor screening without informed consent. 92.4% preferred receiving screening results regardless of outcome. Respondents described benefits to screening for themselves and their families. Conclusions While broadly supporting universal tumor screening without informed consent, respondents also wanted more information shared about the screening policy, as well as their results. These patient preferences should be one of many factors considered when implementing universal screening and can also inform practices regarding both tumor profiling and universal genetic testing, which is becoming more prevalent. Keywords: Lynch syndrome, Universal tumor screening, Informed consent, Service delivery models, Communication, Author(s): Alexander T. Petterson[sup.1,3], Jennifer Garbarini[sup.2] and Maria J. Baker[sup.3] Background Lynch syndrome increases the risk to develop both colorectal and endometrial cancer, as well as cancer of the stomach, [...]
- Published
- 2024
- Full Text
- View/download PDF